CircLASP1 silence strengthens the therapeutic effects of MK‐2206 on nasopharyngeal cancer through upregulating miR‐625

Therapeutic effects of MK‐2206 are largely limited due to the complexity of the pathogenesis of nasopharyngeal cancer (NPC). Here, we aimed to investigate whether and how circLASP1 is involved in the therapeutic effects of MK‐2206 on NPC. We showed circLASP1 was increased while miR‐625 was decreased...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Li‐Na, Liu, Si‐Le, Yang, Yang, Shu, Lu, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154807/
https://www.ncbi.nlm.nih.gov/pubmed/36644819
http://dx.doi.org/10.1111/cas.15725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154807/
https://www.ncbi.nlm.nih.gov/pubmed/36644819
http://dx.doi.org/10.1111/cas.15725

Ejemplares similares